Innovent Biologics and Sanegene Bio USA have entered a collaboration to co-develop SGB-3908, an siRNA drug candidate targeting angiotensinogen (AGT) for hypertension treatment. SGB-3908, an IND-e...
Singapore-based pharmaceutical company, Juniper Biologics, has been awarded the prestigious title of "Most Innovative Oncology Pharmaceutical Company 2023" by the Global Health & Pharma (GHP)...
In the recent times, there has been a steep rise in the sales of human insulin, primarily because of the growing incidence of diabetes all around the world. According to many surveys, the number of...
In the recent times, there has been a steep rise in the sales of human insulin, primarily because of the growing incidence of diabetes all around the world. According to many surveys, the number of...
